Posted in | News

High Flux Isotope Reactor (HFIR) at Oak Ridge National Laboratory Sets World Record for Concentration of Cold Neutrons

Related Stories

The High Flux Isotope Reactor (HFIR) at the Department of Energy's Oak Ridge National Laboratory has set a world record for concentration of cold neutrons that are used to study materials.

Oak Ridge's Ron Crone says the high resolution intensity of the neutrons can study a material's molecular structure deeper than any other facility in the world.

"The HFIR cold source provides the most intense cold neutron beam available," Crone says. "With that, the neutron scattering community is able to use that beam to study the structure of materials."

Upgrading of the Oak Ridge reactor started a year ago, providing new research opportunities.

"The fact that the neutrons are cool provides a wave length which lets them look at the structures in more detail and do smaller samples," Crone says.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Oak Ridge National Laboratory. (2019, March 19). High Flux Isotope Reactor (HFIR) at Oak Ridge National Laboratory Sets World Record for Concentration of Cold Neutrons. AZoNano. Retrieved on April 16, 2024 from https://www.azonano.com/news.aspx?newsID=5441.

  • MLA

    Oak Ridge National Laboratory. "High Flux Isotope Reactor (HFIR) at Oak Ridge National Laboratory Sets World Record for Concentration of Cold Neutrons". AZoNano. 16 April 2024. <https://www.azonano.com/news.aspx?newsID=5441>.

  • Chicago

    Oak Ridge National Laboratory. "High Flux Isotope Reactor (HFIR) at Oak Ridge National Laboratory Sets World Record for Concentration of Cold Neutrons". AZoNano. https://www.azonano.com/news.aspx?newsID=5441. (accessed April 16, 2024).

  • Harvard

    Oak Ridge National Laboratory. 2019. High Flux Isotope Reactor (HFIR) at Oak Ridge National Laboratory Sets World Record for Concentration of Cold Neutrons. AZoNano, viewed 16 April 2024, https://www.azonano.com/news.aspx?newsID=5441.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback